Should FDG PET/CT be used for the initial staging of breast cancer?

Groheux, David; Hindié, Elif; Rubello, Domenico; Espié, Marc; Baillet, Georges; Giacchetti, Sylvie; Misset, Jean-Louis; Moretti, Jean-Luc

Groheux, David; Hindié, Elif; Rubello, Domenico; Espié, Marc; Baillet, Georges; Giacchetti, Sylvie; Misset, Jean-Louis; Moretti, Jean-Luc.

Affiliation

Groheux D; Department of Nuclear Medicine, Hôpital Saint-Louis, Assistance publique-Hopitaux de Paris, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France.

Eur J Nucl Med Mol Imaging ; 36(10): 1539-42, 2009 Oct.

Article in En | MEDLINE | ID: mdl-19449002

Subject(s)

Breast Neoplasms/diagnostic imaging; Fluorodeoxyglucose F18; Radiopharmaceuticals; Axilla; Breast Neoplasms/pathology; Female; Fluorine Radioisotopes; Humans; Lymph Node Excision; Neoplasm Metastasis/diagnosis; Neoplasm Metastasis/diagnostic imaging; Neoplasm Staging/methods; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Radiopharmaceuticals / Fluorodeoxyglucose F18 Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2009 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google